visiongain Logo.png
Macular Degeneration (AMD) and Other Retinal Diseases Drugs market is projected to grow at a CAGR of 7.4% by 2033: Visiongain
October 10, 2023 06:12 ET | Visiongain Reports Ltd
Visiongain has published a new report: Macular Degeneration (AMD) and Other Retinal Diseases Drugs Market Report 2023-2033: Forecasts by Disease Indication (AMD, Diabetic Macular Edema, Diabetic...
Persistence Market Research
Macular Degeneration Treatment Market, 2022: Industry surge ahead at a CAGR of 7.4% to reach US$ 18.8 Bn in 2032 - Persistence Market Research
November 03, 2022 09:30 ET | Persistence Market Research
New York , Nov. 03, 2022 (GLOBE NEWSWIRE) -- The global macular degeneration treatment market recorded a CAGR of 6.2% in the last 9 years from 2012 to 2021 and reached a market value of around US$...